These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16279684)

  • 1. [Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
    Nishizawa Y; Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():469-74. PubMed ID: 16279684
    [No Abstract]   [Full Text] [Related]  

  • 2. [X-linked hypophosphatemic vitamin D resistant rickets: Pathogenesis, pathophysiology, and therapy].
    Tanaka H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():556-61. PubMed ID: 16523954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regulation of fibroblast growth factor 23 in metabolic bone diseases].
    Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():486-91. PubMed ID: 16279687
    [No Abstract]   [Full Text] [Related]  

  • 4. [From gene to disease; hypophosphataemic rickets and the PHEX gene].
    Jansen M; van Dael CM; Verrijn Stuart AA; van der Hout AH; Rump P
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1390-4. PubMed ID: 16841587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [X-linked hypophosphatemic rickets].
    Tanaka H
    Nihon Rinsho; 2006 Jun; Suppl 2():120-5. PubMed ID: 16817365
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():523-8. PubMed ID: 16279694
    [No Abstract]   [Full Text] [Related]  

  • 7. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.
    Quarles LD
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E1-9. PubMed ID: 12791601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF23, hypophosphatemia, and rickets: has phosphatonin been found?
    Strewler GJ
    Proc Natl Acad Sci U S A; 2001 May; 98(11):5945-6. PubMed ID: 11371627
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autosomal dominant hypophosphatemic rickets/osteomalacia].
    Tanaka H
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():529-33. PubMed ID: 16279695
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait.
    Goji K; Ozaki K; Sadewa AH; Nishio H; Matsuo M
    J Clin Endocrinol Metab; 2006 Feb; 91(2):365-70. PubMed ID: 16303832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wrickkened pathways of FGF23, MEPE and PHEX.
    Rowe PS
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):264-81. PubMed ID: 15470265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of Fgf23 in Hyp mice.
    Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and molecular genetic study of hypophosphatemic rickets in children.
    Cho HY; Lee BH; Kang JH; Ha IS; Cheong HI; Choi Y
    Pediatr Res; 2005 Aug; 58(2):329-33. PubMed ID: 16055933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibroblast growth factor 23 (FGF 23): a new fosfaturic hormone?].
    Negri AL
    Nefrologia; 2003; 23(6):478-81. PubMed ID: 15002780
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic advances, biochemical and clinical features and critical approach to treatment of patients with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Sodini F; Galli L; Vanacore T; Fiore L; Saggese G
    Pediatr Endocrinol Rev; 2004 Jun; 1(4):361-79. PubMed ID: 16437029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism.
    Rowe PS
    Exp Nephrol; 1997; 5(5):355-63. PubMed ID: 9386970
    [No Abstract]   [Full Text] [Related]  

  • 19. Two novel PHEX mutations in Taiwanese patients with X-linked hypophosphatemic rickets.
    Lo FS; Kuo MT; Wang CJ; Chang CH; Lee ZL; Van YH
    Nephron Physiol; 2006; 103(4):p157-63. PubMed ID: 16636593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of hypophosphatemic rickets.
    Jan de Beur SM; Levine MA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2467-73. PubMed ID: 12050201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.